A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds
|
|||||
       |
 Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital 
Global venture investment dollars in the third quarter of 2023 rose somewhat from the previous quarter, but remained at about the same level for the past 12 months. . . . → Read More: Infographic – Global Q3 Venture Funding Levels Off One comment - (Comments are closed) Finance entrepreneurs, equity, investment, mathematics, semiconductors, statistics, venture capital 
A company offering a biomanufacturing process it says is more efficient and scalable than conventional bio-production methods is raising $9.5 million in its first venture round. . . . → Read More: Biomanufacturing Company Gains $9.5M in Early Funds One comment - (Comments are closed) Finance, New products biotechnology, chemistry, economics, engineering, entrepreneurs, equity, genomics, investment, Japan, life sciences, manufacturing, mathematics, physical sciences, software, university, venture capital 
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K. . . . → Read More: Industry-Academic Center to Boost Rare Disease Therapies Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, genomics, grant, investment, life sciences, pharmaceuticals, U.K., university, venture capital 
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies 
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, FDA, investment, life sciences, pharmaceuticals, preclinical, psychiatric, venture capital 
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company 
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments 
Since the start of 2021, most news has been gloomy about venture investments, but a report last week suggests corporate venture capital funding worldwide is picking up. . . . → Read More: Infographic – Some Good Corporate Venture Fund News Comments are closed Finance economics, entrepreneurs, equity, investment, statistics, venture capital 
A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds. . . . → Read More: Long-Acting Drug Start-Up Raises $4M in Seed Funds Comments are closed Finance, New products biomedical, chemistry, engineering, entrepreneurs, equity, investment, life sciences, materials science, mathematics, pharmaceuticals, physical sciences, robotics, venture capital |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts